Browse > Article
http://dx.doi.org/10.4333/KPS.2005.35.5.375

Simultaneous Determination of Prostaglandin E1 and Prostaglandin E1 Ethyl Ester in Hairless Mouse Skin Homogenate by High-Performance Liquid Chromatography  

Choi, Han-Gon (College of Pharmacy, Yeungnam University)
Kim, Ji-Hyun (College of Pharmacy, Yeungnam University)
Li, Dong-Xun (College of Pharmacy, Yeungnam University)
Piao, Ming-Guan (College of Pharmacy, Yeungnam University)
Kwon, Tae-Hyub (College of Pharmacy, Yeungnam University)
Woo, Jong-Soo (College of Pharmacy, Yeungnam University)
Choi, Young-Wook (College of Pharmacy, Chung-Ang University)
Yoo, Bang-Kyu (College of Pharmacy, Yeungnam University)
Yong, Chul-Soon (College of Pharmacy, Yeungnam University)
Publication Information
Journal of Pharmaceutical Investigation / v.35, no.5, 2005 , pp. 375-381 More about this Journal
Abstract
A rapid and specific high-performance liquid chromatographic method was developed and validated for the simultaneous determination of prostaglandin $E_{1}\;(PGE_{1})$ and prostaglandin $E_{1}$ ethyl ester $(PGE_{1}-EE)$ in hairless mouse skin homogenate. The sample treatment procedure involved deproteination and precipitation by acetonitrile. $PGE_{1}$ and $PGE_{1}-EE$ in supernatant were separated in a reversed-phase C18 column without being interfered by other components present in hairless mouse skin homogenate. 9-Anthracenecarboxylic acid was used as an internal standard. The retention times of $PGE_{1}$, 9-anthracenecarboxylic acid and $PGE_{1}-EE$ were, 4.5, 9.5 and 18.0 min, respectively. The assay showed linearity from 1 to $40\;{\mu}g/ml$ for both $PGE_{1}$ and $PGE_{1}-EE$. Precision expressed as RSD ranged from 2.3 to 14.1 % for $PGE_{1}$ and 1.6 to 11.0% for $PGE_{1}-EE$. Accuracy ranged from 100.5 to 119.6 % for $PGE_{1}$ and from 98.0 to 103.7% for $PGE_{1}-EE$. This method was employed successfully to follow the time course of concentrations of $PGE_{1}$ and $PGE_{1}-EE$ in hairless mouse skin homogenate for stability study.
Keywords
Prostaglandin $E_{1}\\\(PGE_{1})$; Prostaglandin $E_{1}$ ethyl ester $(PGE_{1}-EE)$; HPLC;
Citations & Related Records
연도 인용수 순위
  • Reference
1 K.B. Sloan, Prodrugs for dermal delivery, Adv. Drug Del. Rev., 3, 67-101 (1989)   DOI   ScienceOn
2 J. Rautio, H. Taipale and J. Gynther, In vitro evaluation of acyloxyalkyI ester as dermal prodrugs of detoprofen and naproxen, J. Pharm. Sci., 87, 1662-1628 (1998)
3 G.B. Kasting, R.L. Smith, B.D. Andersom, K.B. Sloan and M.C. Dekker, Prodrugs for dermal Delivery; Solubility, Molecular Size, and Functional Group Effects. In Prodrugs, Topical and Ocular Drug Delivery, New York, 117-161(1992)
4 R.E. Nellans and L.R. Ellis, Pharmacological erection; diagnosis and treatment applications in 69 patients, J. Urol., 138, 52-54 (1987)
5 P. Halter, Trends in urology, Med Device Diagn. Industry, 12, 52-54 (1990)
6 J.R. White and R.K. Campbell, Drug induced male sexual dysfunction., U.S. Pharmacist Diabetes Supplement. Complications, November, 44-47(1990)
7 Y. Mizushima, Lipid microspheres (Lipid emulsions) as a drug carries-overview, Adv. Drug Del. Rev., 20, 113-115 (1996)   DOI   ScienceOn
8 H. Porst, The rationale for prostaglandin $E_1$ in erectile failure: a survey of worldwide experience, J. Urol., 155, 802-815 (1996)   DOI   ScienceOn
9 J.D. Engel and K.T. McVary, Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy, Urology, 51, 687-692 (1988)   DOI   ScienceOn
10 E.D. Kim and K.T. McVary, Topical prostaglandin $E_1$ for the treatment of erectile dysfunction, J. Urol.15, 3, 1828-1830 (1995)
11 NIH Concensus Conference, Development Panel on Impotence, JAMA, 270, 83-90 (1993)   DOI
12 M. Maggi, S. Filippe and F. Ledda, Erectile dysfunction: from biochemical pharmacology to advances in medical therapy, Eur. J. Endocrinol., 143, 143-154 (2000)   DOI   ScienceOn
13 H. Wendel and F.J. Braun, Transdermal prostaglandin composition, U.S. Patent, 5, 380, 760 (1995)
14 G.W. Peng and W.L. Chiou, Analysis of drugs and other toxic substances in biological samples for pharmacokinet studies, J. Chromatogr. B, 531, 3-50 (1990)   DOI   ScienceOn
15 A. Parra, J. Garcia-Villanova, V. Rodenas and MD. Gomez, First and second derivative spectrophotometric determination of cefoperazone and sulbactam in injections, J. Pharm. Biomed. Anal., 12, 653-657 (1994)   DOI   ScienceOn
16 H. Mahgoub and F.A. Aly, UV-spectrophotometric determination of ampicillin sodium and sulbactam sodium in two-component mixtures, J. Pharm. Biomed. Anal., 17, 1723-1728 (1998)
17 International Conference on Harmonization, Note for Guidance on Validation of Analytical Procedures: Methodology, Committee for Proprietary Medical Products, CPMP/ICH/281/ 95 Approval 18 December, 1996
18 S. Ahmed, T. Imai and M. Otagiri, Stereoselective hydrolysis and penetration of propranolol prodrugs: in vitro evaluation using hairless mouse skin, J. Pharm. Sci., 84, 877-883 (1995)   DOI   ScienceOn
19 C. Hartmann, J. Smeyers-Verbeke, D.L. Massart and R.D. McDowall, Validation of bioanalytical chromatographic methods, J. Pharm. Biomed. Anal., 17, 193-218 (1998)   DOI   ScienceOn
20 M.T. Sheu, L.-H. Lin, B.W. Spur, P.Y.-K. Wong and H.-S. Chiang, Investigation of the percutaneous penetration of prostaglandin $E_1$ and its ethyl ester, J. Control. Rel., 55, 153-160 (1998)   DOI   ScienceOn
21 United States Pharmacopeia 23, Section 1225,'Validation of Compendial Methods,' United States Pharmacopeia Convention, Inc., Rockville, MD, 1995
22 F. BressolIe, M. Bromet-Petit and M. Audran, Validation of liquid chromatographic and gas chromatographic methods. Applications to pharmacokinetics, J. Chromatogr. B, 686, 3-10 (1996)   DOI   ScienceOn
23 Ph. Hubert, P. Chiap, J. Crommen, B. Boulanger, E. Chapuzet, N. Mercier and S. Bervoas-Martin, P. Chevalier, D. Grandjean, P. Lagorce, M. Lallier, M.C. Laparra, M. Laurentie and J.C. Nivet, The SFSTP guide on the validation of chromatographic methods for drug bioanalysis: from the Washington conference to the laboratory, Analytica Chimica Acta, 391, 135-148 (1999)   DOI   ScienceOn
24 H. Rosing, Y.W. Man, E. Doyle, A. Buh and J.H. Beijnen, Bioanalytical liquid chromatographic method validation: a review of current practices and procedures, J. Liq. Chromatogr. Related Technol., 23, 329-354 (2000)   DOI   ScienceOn
25 R.H. Guy, Current status and future prospects of transdermal drug delivery, Pharm. Res., 13, 1765-1768 (1996)   DOI   ScienceOn
26 R. Igarashi, T. Tdenenaga, T. Matsuda, Distribution of lipid microsphere preparations, Adv. Drug Del. Rev., 20, 147-154 (1996)   DOI   ScienceOn
27 O.I. Linet and F.G. Orrinc, Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction, N. Engl. J. Med., 334, 873-877 (1996)   DOI   ScienceOn
28 S. Braggio, R.J. Barnaby, P. Grossi and M. Cugola, A strategy for validation of bioanalytical methods, J. Pharm. Biomed. Anal. 14, 375-388 (1996)   DOI   ScienceOn